

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.72869965 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.72869965 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 3.63785877 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.50566262 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39565364 |
| 6 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.39009450 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.36813362 |
| 8 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.32726506 |
| 9 | DNA unwinding involved in DNA replication (GO:0006268) | 3.28804694 |
| 10 | IMP biosynthetic process (GO:0006188) | 3.27433410 |
| 11 | DNA strand elongation (GO:0022616) | 3.25085528 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 3.22335779 |
| 13 | definitive hemopoiesis (GO:0060216) | 3.19033939 |
| 14 | megakaryocyte development (GO:0035855) | 3.18696722 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.15019541 |
| 16 | response to peptidoglycan (GO:0032494) | 3.11237890 |
| 17 | IMP metabolic process (GO:0046040) | 3.08742371 |
| 18 | telomere maintenance via recombination (GO:0000722) | 3.07316224 |
| 19 | DNA replication initiation (GO:0006270) | 3.03710240 |
| 20 | * muscle filament sliding (GO:0030049) | 3.00506426 |
| 21 | * actin-myosin filament sliding (GO:0033275) | 3.00506426 |
| 22 | establishment of integrated proviral latency (GO:0075713) | 2.95539428 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93061680 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87883812 |
| 25 | negative regulation of cell killing (GO:0031342) | 2.87883812 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87657926 |
| 27 | ribosome assembly (GO:0042255) | 2.85041019 |
| 28 | mitotic recombination (GO:0006312) | 2.84378995 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80219469 |
| 30 | skeletal muscle contraction (GO:0003009) | 2.78015157 |
| 31 | hepatocyte apoptotic process (GO:0097284) | 2.76973507 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.76045242 |
| 33 | positive regulation of lamellipodium assembly (GO:0010592) | 2.72817736 |
| 34 | protein localization to kinetochore (GO:0034501) | 2.71442061 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70442549 |
| 36 | establishment of viral latency (GO:0019043) | 2.68109452 |
| 37 | negative regulation of necroptotic process (GO:0060546) | 2.67885317 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 2.66115893 |
| 39 | mitotic nuclear envelope disassembly (GO:0007077) | 2.64885303 |
| 40 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.63892290 |
| 41 | telomere maintenance via telomere lengthening (GO:0010833) | 2.61454881 |
| 42 | membrane raft organization (GO:0031579) | 2.61136456 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 2.60728242 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 2.60534804 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.60333062 |
| 46 | B cell mediated immunity (GO:0019724) | 2.57840568 |
| 47 | viral transcription (GO:0019083) | 2.57579574 |
| 48 | formation of translation preinitiation complex (GO:0001731) | 2.56983300 |
| 49 | nuclear pore organization (GO:0006999) | 2.55349386 |
| 50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.54383127 |
| 51 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54164561 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53887404 |
| 53 | translational termination (GO:0006415) | 2.52601070 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52325823 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52325823 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 2.52325823 |
| 57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52325823 |
| 58 | modulation by symbiont of host defense response (GO:0052031) | 2.52325823 |
| 59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52325823 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 2.51498994 |
| 61 | myeloid dendritic cell activation (GO:0001773) | 2.51417639 |
| 62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.48103426 |
| 63 | COPI coating of Golgi vesicle (GO:0048205) | 2.47887205 |
| 64 | Golgi transport vesicle coating (GO:0048200) | 2.47887205 |
| 65 | DNA replication checkpoint (GO:0000076) | 2.47652448 |
| 66 | pinocytosis (GO:0006907) | 2.47559957 |
| 67 | nuclear pore complex assembly (GO:0051292) | 2.46989736 |
| 68 | positive thymic T cell selection (GO:0045059) | 2.46023902 |
| 69 | interferon-gamma production (GO:0032609) | 2.45902429 |
| 70 | pentose-phosphate shunt (GO:0006098) | 2.45717968 |
| 71 | nucleobase biosynthetic process (GO:0046112) | 2.45708943 |
| 72 | cellular hyperosmotic response (GO:0071474) | 2.45295690 |
| 73 | leukocyte aggregation (GO:0070486) | 2.45084786 |
| 74 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.45070780 |
| 75 | NADH metabolic process (GO:0006734) | 2.44522089 |
| 76 | mast cell activation (GO:0045576) | 2.43019913 |
| 77 | membrane disassembly (GO:0030397) | 2.42772422 |
| 78 | nuclear envelope disassembly (GO:0051081) | 2.42772422 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36997669 |
| 80 | purine nucleotide salvage (GO:0032261) | 2.36827094 |
| 81 | * actin-mediated cell contraction (GO:0070252) | 2.35897612 |
| 82 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.35552582 |
| 83 | cellular extravasation (GO:0045123) | 2.35493505 |
| 84 | actin nucleation (GO:0045010) | 2.35491288 |
| 85 | regulation of B cell differentiation (GO:0045577) | 2.35342146 |
| 86 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.34991909 |
| 87 | ribosomal large subunit biogenesis (GO:0042273) | 2.34327699 |
| 88 | negative regulation of ligase activity (GO:0051352) | 2.33972774 |
| 89 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.33972774 |
| 90 | detection of other organism (GO:0098543) | 2.33721355 |
| 91 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.31203222 |
| 92 | protein maturation by protein folding (GO:0022417) | 2.30150937 |
| 93 | T cell apoptotic process (GO:0070231) | 2.29405247 |
| 94 | telomere maintenance (GO:0000723) | 2.29152041 |
| 95 | DNA duplex unwinding (GO:0032508) | 2.28947663 |
| 96 | regulation of response to interferon-gamma (GO:0060330) | 2.28839012 |
| 97 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.28659037 |
| 98 | DNA geometric change (GO:0032392) | 2.28253436 |
| 99 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.27978235 |
| 100 | mitotic chromosome condensation (GO:0007076) | 2.27919606 |
| 101 | regulation of spindle organization (GO:0090224) | 2.26878567 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.26794676 |
| 103 | angiogenesis involved in wound healing (GO:0060055) | 2.26637858 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.26573735 |
| 105 | response to interferon-beta (GO:0035456) | 2.26321256 |
| 106 | telomere organization (GO:0032200) | 2.26303713 |
| 107 | ribosomal small subunit biogenesis (GO:0042274) | 2.26133466 |
| 108 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.25973704 |
| 109 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.25304828 |
| 110 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.25246692 |
| 111 | translational elongation (GO:0006414) | 2.25027055 |
| 112 | purine nucleobase metabolic process (GO:0006144) | 2.24515301 |
| 113 | response to protozoan (GO:0001562) | 2.24318089 |
| 114 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.24075804 |
| 115 | positive regulation of interferon-alpha production (GO:0032727) | 2.23672973 |
| 116 | detection of bacterium (GO:0016045) | 2.23453691 |
| 117 | protein localization to chromosome, centromeric region (GO:0071459) | 2.23257335 |
| 118 | B cell receptor signaling pathway (GO:0050853) | 2.23193504 |
| 119 | response to type I interferon (GO:0034340) | 2.22780065 |
| 120 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.22397463 |
| 121 | NADPH regeneration (GO:0006740) | 2.21495839 |
| 122 | negative thymic T cell selection (GO:0045060) | 2.21362657 |
| 123 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.21361427 |
| 124 | AMP metabolic process (GO:0046033) | 2.21330733 |
| 125 | type I interferon signaling pathway (GO:0060337) | 2.21033494 |
| 126 | cellular response to type I interferon (GO:0071357) | 2.21033494 |
| 127 | negative T cell selection (GO:0043383) | 2.20005342 |
| 128 | respiratory burst (GO:0045730) | 2.19787762 |
| 129 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.19380889 |
| 130 | T cell homeostasis (GO:0043029) | 2.18999886 |
| 131 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.18988248 |
| 132 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.18869112 |
| 133 | negative regulation of interleukin-12 production (GO:0032695) | 2.18208979 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.18073224 |
| 135 | DNA topological change (GO:0006265) | 2.17650967 |
| 136 | translational initiation (GO:0006413) | 2.17219511 |
| 137 | purine nucleobase biosynthetic process (GO:0009113) | 2.16249892 |
| 138 | myeloid cell activation involved in immune response (GO:0002275) | 2.15709035 |
| 139 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.15392018 |
| 140 | regulation of necroptotic process (GO:0060544) | 2.15057687 |
| 141 | neutrophil activation (GO:0042119) | 2.15014062 |
| 142 | morphogenesis of an endothelium (GO:0003159) | 2.14944045 |
| 143 | endothelial tube morphogenesis (GO:0061154) | 2.14944045 |
| 144 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.14660402 |
| 145 | regulation of translational termination (GO:0006449) | 2.14456745 |
| 146 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.13773836 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.12822339 |
| 148 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.12742386 |
| 149 | positive regulation of macrophage differentiation (GO:0045651) | 2.12461849 |
| 150 | T cell migration (GO:0072678) | 2.12014625 |
| 151 | defense response to protozoan (GO:0042832) | 2.11867894 |
| 152 | regulation of interferon-alpha production (GO:0032647) | 2.11802737 |
| 153 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.11566365 |
| 154 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.11175665 |
| 155 | regulation of superoxide anion generation (GO:0032928) | 2.10471906 |
| 156 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.10034545 |
| 157 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.09969352 |
| 158 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.09969352 |
| 159 | tricarboxylic acid cycle (GO:0006099) | 2.09826098 |
| 160 | protein targeting to ER (GO:0045047) | 2.09606616 |
| 161 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.09359599 |
| 162 | pore complex assembly (GO:0046931) | 2.09144429 |
| 163 | cotranslational protein targeting to membrane (GO:0006613) | 2.09014823 |
| 164 | positive regulation of interferon-beta production (GO:0032728) | 2.08566276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.83596859 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.50291797 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.14456468 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85315163 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.78947575 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76660401 |
| 7 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.68653388 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65613651 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50156116 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41347482 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40437388 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38253752 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.36121793 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35255916 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34288608 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33179819 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30608090 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08128425 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05452983 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04413096 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95513891 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.94151658 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92601055 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89812589 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86740027 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85915938 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82911853 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.78289235 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.77589639 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77321296 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72654092 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.72538367 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70449713 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.70280548 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70137887 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.66906249 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65668204 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65294519 |
| 39 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.64317685 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63851396 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63109291 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62800111 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.60799495 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58067518 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57205844 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56304600 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54491985 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53906000 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49889836 |
| 50 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49524890 |
| 51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48759408 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46110398 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45989898 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.45795507 |
| 55 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43370451 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43042204 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40328364 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38847041 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.38095934 |
| 60 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38030126 |
| 61 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37410877 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36715411 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35569057 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33926424 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33200351 |
| 66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29310911 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29001042 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.28746774 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25889201 |
| 70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25481129 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24877443 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24486569 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23780365 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21813573 |
| 75 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.21007248 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19377585 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18565257 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18399670 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17197626 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16766497 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16626283 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16159308 |
| 83 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.15553319 |
| 84 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14199947 |
| 85 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14118018 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13831925 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12636821 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11688325 |
| 89 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11590336 |
| 90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11363265 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10396679 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09242980 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08981576 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07817922 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06461710 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06024917 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05402918 |
| 98 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.04241988 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04095109 |
| 100 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03965094 |
| 101 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03812021 |
| 102 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.03624130 |
| 103 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01597728 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00916344 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99822738 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99815973 |
| 107 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99615669 |
| 108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98900151 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97937172 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97729182 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97585084 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97547267 |
| 113 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97457114 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96914541 |
| 115 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95179354 |
| 116 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.94433312 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93182517 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90589768 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89269094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.36725610 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.11458216 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.97806131 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.48081987 |
| 5 | MP0005671_abnormal_response_to | 2.47161725 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.47087082 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.34164156 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 2.32683466 |
| 9 | MP0009785_altered_susceptibility_to | 2.25413133 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.24147564 |
| 11 | MP0003436_decreased_susceptibility_to | 2.20725928 |
| 12 | MP0000685_abnormal_immune_system | 2.12871248 |
| 13 | MP0001800_abnormal_humoral_immune | 2.11848724 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.11832564 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.10183235 |
| 16 | MP0003077_abnormal_cell_cycle | 2.08579482 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.08276846 |
| 18 | MP0002398_abnormal_bone_marrow | 2.03865869 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.03672066 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.02563765 |
| 21 | MP0001819_abnormal_immune_cell | 2.01324626 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.99213195 |
| 23 | MP0005025_abnormal_response_to | 1.93101197 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.92736374 |
| 25 | MP0008057_abnormal_DNA_replication | 1.92016251 |
| 26 | MP0002723_abnormal_immune_serum | 1.90841707 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.89957568 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.89589672 |
| 29 | MP0006054_spinal_hemorrhage | 1.89502742 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.88793629 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.88793629 |
| 32 | MP0002419_abnormal_innate_immunity | 1.87422222 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.86030956 |
| 34 | MP0000749_muscle_degeneration | 1.85174657 |
| 35 | MP0003646_muscle_fatigue | 1.84652946 |
| 36 | MP0000490_abnormal_crypts_of | 1.84564786 |
| 37 | MP0004233_abnormal_muscle_weight | 1.82726396 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.80951845 |
| 39 | MP0001790_abnormal_immune_system | 1.75224124 |
| 40 | MP0005387_immune_system_phenotype | 1.75224124 |
| 41 | MP0002722_abnormal_immune_system | 1.73204739 |
| 42 | MP0002405_respiratory_system_inflammati | 1.73101937 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.71874215 |
| 44 | MP0000716_abnormal_immune_system | 1.71792375 |
| 45 | MP0003303_peritoneal_inflammation | 1.71023297 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.70833052 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.69356046 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.69115318 |
| 49 | MP0003724_increased_susceptibility_to | 1.66746948 |
| 50 | MP0010307_abnormal_tumor_latency | 1.64368875 |
| 51 | MP0000751_myopathy | 1.64301615 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.59718051 |
| 53 | MP0001853_heart_inflammation | 1.59443765 |
| 54 | MP0009278_abnormal_bone_marrow | 1.59197745 |
| 55 | MP0002429_abnormal_blood_cell | 1.58700978 |
| 56 | MP0008260_abnormal_autophagy | 1.54516675 |
| 57 | MP0000858_altered_metastatic_potential | 1.50945269 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.49779471 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.48539379 |
| 60 | MP0001873_stomach_inflammation | 1.47141902 |
| 61 | MP0002006_tumorigenesis | 1.46423958 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.46268429 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.46256404 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.43020641 |
| 65 | MP0008058_abnormal_DNA_repair | 1.42759835 |
| 66 | MP0000747_muscle_weakness | 1.38411586 |
| 67 | MP0004185_abnormal_adipocyte_glucose | 1.35273612 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.32948031 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.32217200 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.30982867 |
| 71 | MP0000759_abnormal_skeletal_muscle | 1.29446873 |
| 72 | MP0006082_CNS_inflammation | 1.28554649 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.27946266 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27872503 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.26825762 |
| 76 | MP0003448_altered_tumor_morphology | 1.25334730 |
| 77 | MP0003566_abnormal_cell_adhesion | 1.25140486 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.25037479 |
| 79 | MP0005330_cardiomyopathy | 1.22119627 |
| 80 | MP0004947_skin_inflammation | 1.21957162 |
| 81 | MP0000350_abnormal_cell_proliferation | 1.18858354 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.18037343 |
| 83 | MP0002132_abnormal_respiratory_system | 1.17493003 |
| 84 | MP0002269_muscular_atrophy | 1.13988070 |
| 85 | MP0002106_abnormal_muscle_physiology | 1.13734498 |
| 86 | MP0002095_abnormal_skin_pigmentation | 1.12848115 |
| 87 | MP0005023_abnormal_wound_healing | 1.11569895 |
| 88 | MP0000015_abnormal_ear_pigmentation | 1.10193641 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.07436460 |
| 90 | MP0003950_abnormal_plasma_membrane | 1.05689763 |
| 91 | MP0002796_impaired_skin_barrier | 1.04275846 |
| 92 | MP0001915_intracranial_hemorrhage | 1.04198048 |
| 93 | MP0003866_abnormal_defecation | 1.02145012 |
| 94 | MP0001730_embryonic_growth_arrest | 1.00226014 |
| 95 | MP0005165_increased_susceptibility_to | 0.99936195 |
| 96 | MP0003943_abnormal_hepatobiliary_system | 0.99840201 |
| 97 | MP0003279_aneurysm | 0.99495080 |
| 98 | MP0008932_abnormal_embryonic_tissue | 0.99237049 |
| 99 | MP0000343_altered_response_to | 0.99127023 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.98705383 |
| 101 | MP0000313_abnormal_cell_death | 0.98013628 |
| 102 | MP0003828_pulmonary_edema | 0.96352258 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.93784456 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93100595 |
| 105 | MP0003075_altered_response_to | 0.92248396 |
| 106 | MP0003786_premature_aging | 0.91182890 |
| 107 | MP0005166_decreased_susceptibility_to | 0.91120235 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.89955896 |
| 109 | MP0002933_joint_inflammation | 0.89624509 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.87267057 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.87198597 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.86683560 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.86085019 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.85057828 |
| 115 | MP0001851_eye_inflammation | 0.84976352 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.84676516 |
| 117 | MP0009697_abnormal_copulation | 0.82418138 |
| 118 | MP0003984_embryonic_growth_retardation | 0.82187212 |
| 119 | MP0002088_abnormal_embryonic_growth/wei | 0.79383888 |
| 120 | MP0005380_embryogenesis_phenotype | 0.79151042 |
| 121 | MP0001672_abnormal_embryogenesis/_devel | 0.79151042 |
| 122 | MP0008469_abnormal_protein_level | 0.77969628 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.75632948 |
| 124 | MP0001697_abnormal_embryo_size | 0.74153982 |
| 125 | * MP0002080_prenatal_lethality | 0.72750213 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.70274104 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.68686617 |
| 128 | MP0005390_skeleton_phenotype | 0.67760852 |
| 129 | MP0000249_abnormal_blood_vessel | 0.65290445 |
| 130 | MP0001191_abnormal_skin_condition | 0.63941685 |
| 131 | MP0003091_abnormal_cell_migration | 0.63580213 |
| 132 | MP0004197_abnormal_fetal_growth/weight/ | 0.61824337 |
| 133 | MP0000733_abnormal_muscle_development | 0.61543678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Muscle fiber inclusion bodies (HP:0100299) | 6.23398723 |
| 2 | * Nemaline bodies (HP:0003798) | 6.13150583 |
| 3 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.08786060 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.58654958 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 4.25779888 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.12797739 |
| 7 | Rhabdomyolysis (HP:0003201) | 3.82765920 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.67583193 |
| 9 | Increased connective tissue (HP:0009025) | 3.66451118 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64977320 |
| 11 | Thrombocytosis (HP:0001894) | 3.53789207 |
| 12 | Eczematoid dermatitis (HP:0000976) | 3.50954472 |
| 13 | Myositis (HP:0100614) | 3.39505787 |
| 14 | Myopathic facies (HP:0002058) | 3.37581346 |
| 15 | IgM deficiency (HP:0002850) | 3.31432833 |
| 16 | * Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.31258530 |
| 17 | Recurrent viral infections (HP:0004429) | 3.17414880 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.11713058 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.05607911 |
| 20 | Chronic otitis media (HP:0000389) | 3.03862113 |
| 21 | Myoglobinuria (HP:0002913) | 2.97314612 |
| 22 | Progressive muscle weakness (HP:0003323) | 2.96145810 |
| 23 | * EMG: myopathic abnormalities (HP:0003458) | 2.94040601 |
| 24 | Distal arthrogryposis (HP:0005684) | 2.90144369 |
| 25 | Aplastic anemia (HP:0001915) | 2.89163283 |
| 26 | Muscle stiffness (HP:0003552) | 2.84790067 |
| 27 | Fatigue (HP:0012378) | 2.79545355 |
| 28 | * Neck muscle weakness (HP:0000467) | 2.79231906 |
| 29 | Cellulitis (HP:0100658) | 2.72759026 |
| 30 | Reticulocytopenia (HP:0001896) | 2.70107173 |
| 31 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 2.69375178 |
| 32 | Recurrent bronchitis (HP:0002837) | 2.68954125 |
| 33 | Abnormality of T cells (HP:0002843) | 2.66824703 |
| 34 | Cutaneous melanoma (HP:0012056) | 2.66764229 |
| 35 | Petechiae (HP:0000967) | 2.62867349 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.60979706 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.60410509 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.55128657 |
| 39 | Orchitis (HP:0100796) | 2.54284999 |
| 40 | Agnosia (HP:0010524) | 2.53230001 |
| 41 | T lymphocytopenia (HP:0005403) | 2.51160968 |
| 42 | Chromsome breakage (HP:0040012) | 2.50293816 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.48228859 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.42614687 |
| 45 | Ulnar deviation of the wrist (HP:0003049) | 2.41326016 |
| 46 | Amaurosis fugax (HP:0100576) | 2.40532110 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.37821129 |
| 48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36607221 |
| 49 | Acute myeloid leukemia (HP:0004808) | 2.35533817 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.35533420 |
| 51 | Subaortic stenosis (HP:0001682) | 2.33697519 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.33697519 |
| 53 | Myelodysplasia (HP:0002863) | 2.33424180 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.32483643 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.31569810 |
| 56 | Pelvic girdle muscle weakness (HP:0003749) | 2.31568644 |
| 57 | Pustule (HP:0200039) | 2.31183637 |
| 58 | Lymphoma (HP:0002665) | 2.29568016 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.28471451 |
| 60 | Entropion (HP:0000621) | 2.28302706 |
| 61 | Leukocytosis (HP:0001974) | 2.27204781 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.27134885 |
| 63 | Meningitis (HP:0001287) | 2.26988735 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 2.26579874 |
| 65 | Rimmed vacuoles (HP:0003805) | 2.25774850 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24827383 |
| 67 | Difficulty climbing stairs (HP:0003551) | 2.24359589 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23897550 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.22434248 |
| 70 | Lymphopenia (HP:0001888) | 2.22107341 |
| 71 | Optic neuritis (HP:0100653) | 2.21883908 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.21883908 |
| 73 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.21817781 |
| 74 | * Distal lower limb muscle weakness (HP:0009053) | 2.21518835 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21497544 |
| 76 | Obstructive lung disease (HP:0006536) | 2.21497544 |
| 77 | Prostate neoplasm (HP:0100787) | 2.21109695 |
| 78 | Eosinophilia (HP:0001880) | 2.20486121 |
| 79 | Granulocytopenia (HP:0001913) | 2.20315961 |
| 80 | Round ear (HP:0100830) | 2.20214004 |
| 81 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.19109651 |
| 82 | Autoimmune hemolytic anemia (HP:0001890) | 2.18289934 |
| 83 | 11 pairs of ribs (HP:0000878) | 2.18092840 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.16603424 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.16379963 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.15786350 |
| 87 | Basal cell carcinoma (HP:0002671) | 2.15620832 |
| 88 | Birth length less than 3rd percentile (HP:0003561) | 2.13256883 |
| 89 | IgA deficiency (HP:0002720) | 2.13031842 |
| 90 | Panhypogammaglobulinemia (HP:0003139) | 2.11418565 |
| 91 | Increased IgM level (HP:0003496) | 2.11284280 |
| 92 | Degeneration of anterior horn cells (HP:0002398) | 2.10411441 |
| 93 | Abnormality of the anterior horn cell (HP:0006802) | 2.10411441 |
| 94 | Poikiloderma (HP:0001029) | 2.10167642 |
| 95 | IgG deficiency (HP:0004315) | 2.06738971 |
| 96 | B lymphocytopenia (HP:0010976) | 2.06316422 |
| 97 | Abnormality of B cell number (HP:0010975) | 2.06316422 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.06073959 |
| 99 | Progressive external ophthalmoplegia (HP:0000590) | 2.04992016 |
| 100 | Spinal cord lesions (HP:0100561) | 2.04923754 |
| 101 | Syringomyelia (HP:0003396) | 2.04923754 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04609543 |
| 103 | Osteolytic defects of the hand bones (HP:0009699) | 2.04609543 |
| 104 | Recurrent skin infections (HP:0001581) | 2.02952906 |
| 105 | Trismus (HP:0000211) | 2.02792130 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01944121 |
| 107 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01944121 |
| 108 | Difficulty running (HP:0009046) | 2.01636238 |
| 109 | Abnormality of the calcaneus (HP:0008364) | 1.98292519 |
| 110 | Vasculitis (HP:0002633) | 1.97647859 |
| 111 | Gastrointestinal inflammation (HP:0004386) | 1.96236344 |
| 112 | Periodontitis (HP:0000704) | 1.95807157 |
| 113 | Increased mean platelet volume (HP:0011877) | 1.94611089 |
| 114 | Inflammation of the large intestine (HP:0002037) | 1.94456117 |
| 115 | Vacuolated lymphocytes (HP:0001922) | 1.93997669 |
| 116 | Arterial thrombosis (HP:0004420) | 1.92945649 |
| 117 | Paralysis (HP:0003470) | 1.92330388 |
| 118 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91884686 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.91616022 |
| 120 | Stomatitis (HP:0010280) | 1.91268408 |
| 121 | Calcaneovalgus deformity (HP:0001848) | 1.90670147 |
| 122 | Shoulder girdle muscle weakness (HP:0003547) | 1.90650558 |
| 123 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89933990 |
| 124 | Epistaxis (HP:0000421) | 1.88623378 |
| 125 | Osteomyelitis (HP:0002754) | 1.88398305 |
| 126 | Abnormal platelet volume (HP:0011876) | 1.88248984 |
| 127 | Selective tooth agenesis (HP:0001592) | 1.88182060 |
| 128 | * Distal lower limb amyotrophy (HP:0008944) | 1.87884129 |
| 129 | Abnormal number of erythroid precursors (HP:0012131) | 1.86027175 |
| 130 | Urticaria (HP:0001025) | 1.85525338 |
| 131 | Abnormality of the nasal mucosa (HP:0000433) | 1.84952139 |
| 132 | Abnormality of chromosome stability (HP:0003220) | 1.84515250 |
| 133 | Gingival bleeding (HP:0000225) | 1.84065057 |
| 134 | Impaired platelet aggregation (HP:0003540) | 1.84039343 |
| 135 | Abnormal platelet function (HP:0011869) | 1.84039343 |
| 136 | Agammaglobulinemia (HP:0004432) | 1.82019619 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.79977308 |
| 138 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79932976 |
| 139 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79932976 |
| 140 | Nasal polyposis (HP:0100582) | 1.79272329 |
| 141 | Thyroiditis (HP:0100646) | 1.78768284 |
| 142 | Chest pain (HP:0100749) | 1.78494718 |
| 143 | Basal ganglia calcification (HP:0002135) | 1.77839549 |
| 144 | Increased density of long bones (HP:0006392) | 1.77674972 |
| 145 | Severe combined immunodeficiency (HP:0004430) | 1.76527423 |
| 146 | Encephalitis (HP:0002383) | 1.76168709 |
| 147 | Achilles tendon contracture (HP:0001771) | 1.76105723 |
| 148 | Hematochezia (HP:0002573) | 1.75792421 |
| 149 | Pulmonary infiltrates (HP:0002113) | 1.75528713 |
| 150 | Reduced antithrombin III activity (HP:0001976) | 1.74995171 |
| 151 | Skin ulcer (HP:0200042) | 1.74600144 |
| 152 | Clubbing of toes (HP:0100760) | 1.72973869 |
| 153 | Spinal rigidity (HP:0003306) | 1.72743321 |
| 154 | Menorrhagia (HP:0000132) | 1.72589710 |
| 155 | Bone marrow hypocellularity (HP:0005528) | 1.72269873 |
| 156 | Increased IgE level (HP:0003212) | 1.72015687 |
| 157 | Chronic diarrhea (HP:0002028) | 1.71602514 |
| 158 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71422559 |
| 159 | Myocardial infarction (HP:0001658) | 1.71383751 |
| 160 | Rough bone trabeculation (HP:0100670) | 1.71331310 |
| 161 | Vertebral compression fractures (HP:0002953) | 1.70439292 |
| 162 | Calf muscle hypertrophy (HP:0008981) | 1.70276088 |
| 163 | Colitis (HP:0002583) | 1.68256490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.32227347 |
| 2 | OBSCN | 3.28601097 |
| 3 | KIT | 2.37956696 |
| 4 | TXK | 2.29147450 |
| 5 | STK10 | 2.24087155 |
| 6 | MAP3K14 | 2.13945108 |
| 7 | JAK3 | 2.09439176 |
| 8 | IRAK4 | 2.04168148 |
| 9 | CDC7 | 2.03615573 |
| 10 | RIPK4 | 1.99355228 |
| 11 | WEE1 | 1.97162005 |
| 12 | PRPF4B | 1.96703287 |
| 13 | NME2 | 1.90380863 |
| 14 | VRK2 | 1.86137922 |
| 15 | ZAP70 | 1.84353999 |
| 16 | TSSK6 | 1.79464800 |
| 17 | BTK | 1.79043115 |
| 18 | RPS6KA4 | 1.78575548 |
| 19 | PIM2 | 1.78172625 |
| 20 | EEF2K | 1.72847931 |
| 21 | TGFBR1 | 1.71183843 |
| 22 | TEC | 1.70184798 |
| 23 | MAP2K3 | 1.65659464 |
| 24 | TYK2 | 1.64831222 |
| 25 | BUB1 | 1.61467140 |
| 26 | NEK9 | 1.60809003 |
| 27 | CLK1 | 1.49854080 |
| 28 | PBK | 1.47050318 |
| 29 | BLK | 1.45278506 |
| 30 | TBK1 | 1.44671422 |
| 31 | ACVR1B | 1.41272453 |
| 32 | RPS6KB2 | 1.41129136 |
| 33 | MAP3K13 | 1.40884217 |
| 34 | TESK2 | 1.35785696 |
| 35 | FLT3 | 1.35778467 |
| 36 | NEK1 | 1.33341439 |
| 37 | KDR | 1.32942308 |
| 38 | PIM1 | 1.29185283 |
| 39 | LRRK2 | 1.27296707 |
| 40 | BRSK2 | 1.26753284 |
| 41 | NEK2 | 1.26576385 |
| 42 | FES | 1.26026130 |
| 43 | IKBKE | 1.25976417 |
| 44 | MKNK1 | 1.25366366 |
| 45 | BMPR2 | 1.24011359 |
| 46 | PKN2 | 1.22622069 |
| 47 | PAK4 | 1.21847714 |
| 48 | IKBKB | 1.20956851 |
| 49 | ITK | 1.20355783 |
| 50 | IRAK3 | 1.19703536 |
| 51 | MATK | 1.16527454 |
| 52 | TGFBR2 | 1.16013671 |
| 53 | PASK | 1.15414407 |
| 54 | SRPK1 | 1.11108643 |
| 55 | ATR | 1.09745335 |
| 56 | CSF1R | 1.08856162 |
| 57 | EIF2AK1 | 1.07549293 |
| 58 | MAP3K8 | 1.04628377 |
| 59 | SMG1 | 1.04338922 |
| 60 | CDK4 | 1.04017629 |
| 61 | STK4 | 1.01000441 |
| 62 | MOS | 1.00150978 |
| 63 | MAP3K10 | 0.99427118 |
| 64 | CDK7 | 0.98720706 |
| 65 | ARAF | 0.98360059 |
| 66 | CHUK | 0.98060687 |
| 67 | LCK | 0.97066130 |
| 68 | SYK | 0.96201488 |
| 69 | MST1R | 0.95166653 |
| 70 | PHKG2 | 0.94639438 |
| 71 | PHKG1 | 0.94639438 |
| 72 | EPHA2 | 0.92801467 |
| 73 | EIF2AK3 | 0.91913361 |
| 74 | MST4 | 0.90181338 |
| 75 | CDK12 | 0.89922081 |
| 76 | VRK1 | 0.89169202 |
| 77 | CDK6 | 0.87523801 |
| 78 | HCK | 0.86814532 |
| 79 | TTN | 0.86283730 |
| 80 | TRPM7 | 0.86055521 |
| 81 | AURKB | 0.83492324 |
| 82 | GRK6 | 0.82531313 |
| 83 | LYN | 0.80486892 |
| 84 | CSK | 0.79914157 |
| 85 | MAP3K3 | 0.79173592 |
| 86 | MKNK2 | 0.78313109 |
| 87 | TIE1 | 0.77565700 |
| 88 | NLK | 0.77285184 |
| 89 | FGFR3 | 0.76031721 |
| 90 | TESK1 | 0.75860828 |
| 91 | ERN1 | 0.75688731 |
| 92 | MAP3K1 | 0.75429688 |
| 93 | PLK4 | 0.73668714 |
| 94 | EPHB1 | 0.73192498 |
| 95 | CDK8 | 0.72143933 |
| 96 | DYRK3 | 0.69689124 |
| 97 | LIMK1 | 0.68891344 |
| 98 | PIK3CG | 0.68008069 |
| 99 | MAP3K11 | 0.67198778 |
| 100 | PLK1 | 0.67127493 |
| 101 | JAK1 | 0.66051846 |
| 102 | TAOK2 | 0.64820007 |
| 103 | ALK | 0.63562817 |
| 104 | FGR | 0.62502850 |
| 105 | STK24 | 0.62464463 |
| 106 | TRIB3 | 0.60214915 |
| 107 | TAOK3 | 0.59720409 |
| 108 | SCYL2 | 0.56710714 |
| 109 | PTK6 | 0.56564664 |
| 110 | MAPK12 | 0.55294817 |
| 111 | MAPKAPK2 | 0.54793958 |
| 112 | NME1 | 0.54163213 |
| 113 | MARK3 | 0.52440417 |
| 114 | FGFR4 | 0.51992207 |
| 115 | EIF2AK2 | 0.51653609 |
| 116 | CDK9 | 0.51597088 |
| 117 | PAK1 | 0.50914647 |
| 118 | KSR2 | 0.50588109 |
| 119 | PLK3 | 0.50188596 |
| 120 | SIK3 | 0.49542654 |
| 121 | BMX | 0.48851387 |
| 122 | BCKDK | 0.48760094 |
| 123 | MAPK11 | 0.48217687 |
| 124 | DAPK1 | 0.47228173 |
| 125 | RPS6KA6 | 0.47145516 |
| 126 | TTK | 0.46114539 |
| 127 | MAP3K12 | 0.45989208 |
| 128 | MAPKAPK3 | 0.45963340 |
| 129 | ZAK | 0.45625160 |
| 130 | STK16 | 0.42517280 |
| 131 | RAF1 | 0.40575446 |
| 132 | ILK | 0.40004558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.43506970 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.65396258 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 2.25198794 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.13300888 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03021653 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97566771 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 1.96749949 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 1.90913084 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87908988 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86601390 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86263470 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.81780019 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81076940 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.78356706 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.73220994 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.63033854 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62612888 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.58590703 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.57894205 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.57351624 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51965416 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48857565 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.47822164 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44485266 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44004639 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42312200 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41372862 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41371064 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.40267031 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.36414789 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.34637236 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34396746 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34295967 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33807282 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32684906 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31938005 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.28741766 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27147810 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.26701950 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24957119 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24879530 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.21969378 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21260705 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18896336 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.17612919 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17543468 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17298780 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15758917 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15242148 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14559750 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 1.12493214 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11373467 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09347791 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09296112 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08294190 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.07827568 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06989203 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 1.06842145 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06351818 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05884374 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03167956 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.99816961 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97881365 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94742391 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94344567 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92481198 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89742549 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89439778 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88486467 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.88118857 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86353761 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.84019827 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.83837547 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.83566465 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83440659 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82976284 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.81242156 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80233334 |
| 79 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77331841 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76377791 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75950989 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75896769 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75430321 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70405869 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.68794492 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68401851 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.68327769 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65481039 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64403773 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63501091 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62314749 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61732225 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61337443 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.60077089 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58979061 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56505272 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.55534468 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55139963 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54730522 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54630667 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54340829 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53929822 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53290981 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53112212 |
| 105 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.52117891 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.52112349 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52016117 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50757953 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.49287512 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49249393 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47803436 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47293220 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47249486 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43370622 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.43335101 |
| 116 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.43283558 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42708944 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42604572 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42228003 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42211337 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41573265 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39725556 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.38472703 |

